Medication info
Pitavon 4 mg (Pitavastatin Calcium)

Pitavon 4 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tablet
Manufacturer / importer
Dongkuk Pharm Co., Ltd.
Appearance
Yellow round film-coated tablet with a score line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202100246 · Approved 2021.01.08 · Insurance code 653404740

Summary

Main use
Improvement of mixed dyslipidemia and primary hypercholesterolemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response. The therapeutic effect of this medicine is maintained with continued use.

Ingredients

Manufacturer
Dongkuk Pharm Co., Ltd.

Efficacy & effects

Improvement of mixed dyslipidemia and primary hypercholesterolemia

  • Hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B
  • elevated triglycerides
View approved original text

This medicine effectively lowers blood levels of total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia. It also helps increase HDL cholesterol levels, improving cardiovascular health. This medicine works best when combined with dietary therapy. It is useful for controlling lipid levels to prevent atherosclerosis and reduce the risk of heart disease. It is important to adjust the method and dosage of administration according to the patient's health condition. Therefore, this medicine is used for treatment related to dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response. The therapeutic effect of this medicine is maintained with continued use.

Precautions

This medicine should not be used in certain patients. For example, it should not be administered to patients with allergies to this drug, those with liver problems, patients with severe liver dysfunction or cholestasis, patients taking cyclosporine, patients with myopathy, pregnant women or women who may become pregnant, nursing mothers, and children. Furthermore, caution should be exercised when administering to patients with compromised kidney function or a history of liver dysfunction, patients who consume alcohol excessively, patients with hypothyroidism or family histories of muscle diseases, the elderly, and patients with severe myasthenia gravis. When taking this medicine, symptoms such as muscle pain, weakness, or signs of liver dysfunction may occur, so if these symptoms appear, discontinue use immediately and consult a doctor. Regular liver function tests should be performed, and it is important to check for liver dysfunction within the first 12 weeks of treatment. This medicine may interact with other drugs, especially if the patient is taking cyclosporine, fibrate drugs, or niacin, so caution is required. Monitoring should be conducted according to the doctor's instructions to observe for muscle-related adverse reactions or worsening kidney function when used in conjunction with this medicine. Older adults may experience adverse reactions more easily due to decreased physiological functions, so caution is advised when taking this medicine. Pregnant or nursing mothers should not take this medication, and women who may become pregnant should ensure pregnancy status before taking it. Safety and efficacy in children have not been established, so it is best not to use it. When taking this medicine, do not split the tablet, and swallow it whole, keeping it out of the reach of children. Also, do not store the medicine in another container after removing it from the original package. Since this medicine is used to treat hypercholesterolemia, it is advisable to undergo thorough testing and to follow a dietary and exercise regimen before starting treatment. Blood lipid levels should be monitored regularly during treatment to confirm treatment efficacy.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 78 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heavy head
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • dyspepsia
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • fatigue
  • palpitations
  • tiredness
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing impairment
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • dysgeusia
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • oculobulbar myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • skin tingling
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to light, so it should be stored in a tightly closed container that can block light. Additionally, it is best to store the medicine at room temperature between 1°C and 30°C. This will help maintain the medicine's effectiveness for a longer period.

Appearance and packaging

Appearance

Yellow round film-coated tablet with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.